Ang Zhou1,2, Joseph B Selvanayagam2,3, Elina Hyppönen1,2,4. 1. Australian Center for Precision Health, University of South Australia Cancer Research Institute, GPO Box 2471, Adelaide, SA 5001, Australia. 2. South Australian Health and Medical Research Institute, North Terrace, Adelaide, SA 5000, Australia. 3. Department of Cardiovascular Medicine, Flinders Medical Centre, Bedford Park, Adelaide, SA 5042, Australia. 4. Population, Policy and Practice, UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, London, UK.
Abstract
AIMS: Low vitamin D status is associated with a higher risk for cardiovascular diseases (CVDs). Although most existing linear Mendelian randomization (MR) studies reported a null effect of vitamin D on CVD risk, a non-linear effect cannot be excluded. Our aim was to apply the non-linear MR design to investigate the association of serum 25-hydroxyvitamin D [25(OH)D] concentration with CVD risk. METHODS AND RESULTS: The non-linear MR analysis was conducted in the UK Biobank with 44 519 CVD cases and 251 269 controls. Blood pressure (BP) and cardiac-imaging-derived phenotypes were included as secondary outcomes. Serum 25(OH)D concentration was instrumented using 35 confirmed genome-wide significant variants.We also estimated the potential reduction in CVD incidence attributable to correction of low vitamin D status. There was a L-shaped association between genetically predicted serum 25(OH)D and CVD risk (Pnon-linear = 0.007), where CVD risk initially decreased steeply with increasing concentrations and levelled off at around 50 nmol/L. A similar association was seen for systolic (Pnon-linear = 0.03) and diastolic (Pnon-linear = 0.07) BP. No evidence of association was seen for cardiac-imaging phenotypes (P = 0.05 for all). Correction of serum 25(OH)D level below 50 nmol/L was predicted to result in a 4.4% reduction in CVD incidence (95% confidence interval: 1.8- 7.3%). CONCLUSION: Vitamin D deficiency can increase the risk of CVD. Burden of CVD could be reduced by population-wide correction of low vitamin D status. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Low vitamin D status is associated with a higher risk for cardiovascular diseases (CVDs). Although most existing linear Mendelian randomization (MR) studies reported a null effect of vitamin D on CVD risk, a non-linear effect cannot be excluded. Our aim was to apply the non-linear MR design to investigate the association of serum 25-hydroxyvitamin D [25(OH)D] concentration with CVD risk. METHODS AND RESULTS: The non-linear MR analysis was conducted in the UK Biobank with 44 519 CVD cases and 251 269 controls. Blood pressure (BP) and cardiac-imaging-derived phenotypes were included as secondary outcomes. Serum 25(OH)D concentration was instrumented using 35 confirmed genome-wide significant variants.We also estimated the potential reduction in CVD incidence attributable to correction of low vitamin D status. There was a L-shaped association between genetically predicted serum 25(OH)D and CVD risk (Pnon-linear = 0.007), where CVD risk initially decreased steeply with increasing concentrations and levelled off at around 50 nmol/L. A similar association was seen for systolic (Pnon-linear = 0.03) and diastolic (Pnon-linear = 0.07) BP. No evidence of association was seen for cardiac-imaging phenotypes (P = 0.05 for all). Correction of serum 25(OH)D level below 50 nmol/L was predicted to result in a 4.4% reduction in CVD incidence (95% confidence interval: 1.8- 7.3%). CONCLUSION: Vitamin D deficiency can increase the risk of CVD. Burden of CVD could be reduced by population-wide correction of low vitamin D status. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Nan Zhang; Yueying Wang; Ziliang Chen; Daiqi Liu; Gary Tse; Panagiotis Korantzopoulos; Konstantinos P Letsas; Christos A Goudis; Gregory Y H Lip; Guangping Li; Zhiwei Zhang; Tong Liu Journal: Front Nutr Date: 2022-06-17
Authors: Keila Valente de Souza de Santana; Sofia Lizarralde Oliver; Marcela Moraes Mendes; Susan Lanham-New; Karen E Charlton; Helena Ribeiro Journal: EClinicalMedicine Date: 2022-04-18
Authors: Ewelina A Dziedzic; Jakub S Gąsior; Izabela Sowińska; Marek Dąbrowski; Piotr Jankowski Journal: J Clin Med Date: 2022-01-28 Impact factor: 4.241
Authors: Ghadeer M Aldawsari; Shaun Sabico; Abir A Alamro; Amal Alenad; Kaiser Wani; Abdullah M Alnaami; Malak N K Khattak; Mohammad S Masoud; Nasser M Al-Daghri; Majed S Alokail Journal: Biology (Basel) Date: 2022-02-11
Authors: Ewelina A Dziedzic; William B Grant; Izabela Sowińska; Marek Dąbrowski; Piotr Jankowski Journal: J Clin Med Date: 2022-01-31 Impact factor: 4.241
Authors: Stefan Pilz; Christian Trummer; Verena Theiler-Schwetz; Martin R Grübler; Nicolas D Verheyen; Balazs Odler; Spyridon N Karras; Armin Zittermann; Winfried März Journal: Nutrients Date: 2022-01-12 Impact factor: 5.717
Authors: William B Grant; Fatme Al Anouti; Barbara J Boucher; Erdinç Dursun; Duygu Gezen-Ak; Edward B Jude; Tatiana Karonova; Pawel Pludowski Journal: Nutrients Date: 2022-02-02 Impact factor: 5.717